The purpose of the current study is to demonstrate non-inferiority of everolimus-eluting bioresorbable vascular scaffold to everolimus-eluting stents in patients with chronic total occlusion regarding the antirestenotic efficacy at 8 to 10-month angiographic follow-up.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
17
Implantation of everolimus-eluting bioresorbable vascular scaffold in chronic total occlusion
Implantation of everolimus-eluting stent in chronic total occlusion
University of Luebeck
Lübeck, Germany
In-stent late lumen loss assessed by angiography
Time frame: 8-10 months after the index procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.